# The Human Medicines (Amendment) Regulations 2019, Regulation 6: Amendment of regulation 42 (conditions for wholesale dealer’s licence)


In regulation 42, after paragraph (3) insert—
“(4) The requirements and obligations contained in a provision of Commission Regulation 2016/161 listed in paragraph (5) have effect as if they were provisions of a wholesale dealer’s licence under this Part.
(5) The provisions mentioned in paragraph (4) are—
(a) Article 10 (verification of the safety features) insofar as it relates to wholesalers;
(b) Article 11 (verification of the authenticity of the unique identifier) insofar as it relates to wholesalers;
(c) Article 12 (unique identifiers which have been decommissioned);
(d) Article 13 (reversing the status of a decommissioned unique identifier) insofar as it relates to wholesalers;
(e) Article 20 (verification of the authenticity of the unique identifier), subject to the exemption contained in Article 21 (derogations from Article 20(b));
(f) Article 22 (decommissioning of unique identifiers); and
(g) Article 24 (actions to be taken in case of tampering or suspected falsification).”.

---
Source: https://www.legislation.gov.uk/uksi/2019/62/regulation/6 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-regulations-2019/regulation-6
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.